E-DRUG: Webinar: Trade secrets: implications for pharmaceutical innovation and access, Sep 24
---------------------------------------------------------------------------
Dear all,
We would like to invite you to the next webinar of the series organized by
the Knowledge Network for Innovation and Access to Medicines, a project of
the Global Health Centre at the Graduate Institute of Geneva, which will
take place on Thursday, September 24, 4pm - 5pm CEST / 10am-11am EDT.
We hope you will be able to join us for this discussion. The webinar will
be recorded and made available a few days after it takes place. A list of
the previous webinars of the series and their recordings and related
materials is available at: https://www.knowledgeportalia.org/webinars
Trade secrets: implications for pharmaceutical innovation and access
Thursday, September 24, 4pm - 5pm CEST / 10am-11am EDT
To join the webinar, please register here:
https://us02web.zoom.us/webinar/register/7516002940004/WN_vXvmwqxzQFG2Cz8U5_FGuQ
Speaker:
David Levine, Associate Professor, Elon University School of Law and
Affiliate Scholar, Center for Internet and Society, Stanford Law School
Papers:
David S. Levine, COVID-19 Trade Secrets and Information Access: an
Overview, July, 2020,
http://infojustice.org/archives/42493
Levine, David S. and Sichelman, Ted M., Why Do Startups Use Trade Secrets?
(April 22, 2018). 94 Notre Dame Law Review 751 (2018), San Diego Legal
Studies Paper No. 18-346,
http://dx.doi.org/10.2139/ssrn.3166834
The implications of intellectual property rights for innovation and access
to medicines is a highly debated topic. While most of the discussion
focuses on patents and other kinds of exclusive rights, much less attention
is paid to trade secrets (namely IPRs on confidential information that may
be sold or licensed).
Trade secrets can restrict access to critical information relevant to product R&D, manufacturing and commercialization, acting as potential barriers hampering the development and widespread use of health technologies.
Professor David Levine will explore how the current Covid-19 pandemic provides a unique opportunity to apply exceptions and limitations foreseen in international trade laws in the public interest to advance equitable access to life saving diagnostics, treatments, medicines, and vaccines that may hinge on robust information access.
The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event.
Recordings of all webinars will be made available afterward at the
Knowledge Portal on Innovation and Access to Medicines
www.knowledgeportalia.org,
a project of the Global Health Centre, Graduate Institute of Geneva. After registering, you will receive a confirmation email with additional information on how to join the webinar using the Zoom platform.
For more information on the activities of the Global Health Centre, visit our website or subscribe to our mailing list:
graduateinstitute.ch/globalhealth.
Marcela Vieira, LLB, MPH
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines
https://www.knowledgeportalia.org/
Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira@graduateinstitute.ch